Home › AstraZeneca in $560 m deal for respiratory firm
 

Keywords :   


AstraZeneca in $560 m deal for respiratory firm

2013-06-10 15:26:14| Biotech - Topix.net

British drugmaker AstraZeneca PLC says it is to acquire Pearl Therapeutics Inc., a Redwood-City, California-based company involved in therapies for asthma and chronic obstructive pulmonary disease for at least $560 million.

Tags: deal firm respiratory astrazeneca

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.05Mooncat Introduces New Hue, Holds Bi-Annual Sale
15.05Eastern North Pacific Tropical Weather Outlook
15.05European Wax Center\'s EWC Treat Brightening Ingrown Hair Wipes Awarded
15.05Atlantic Tropical Weather Outlook
15.05PBE Makes Investment in Plus-Size Adult Incontinence Products
15.05Flint Group retains EcoVadis Silver Medal for 2024
15.05Mark Andy hosts student workshop in Poland
15.05Kenvue Launches Aveeno Baby Healthy Start Wash and Balm
More »